DK1220667T3 - Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden - Google Patents

Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden

Info

Publication number
DK1220667T3
DK1220667T3 DK00964272T DK00964272T DK1220667T3 DK 1220667 T3 DK1220667 T3 DK 1220667T3 DK 00964272 T DK00964272 T DK 00964272T DK 00964272 T DK00964272 T DK 00964272T DK 1220667 T3 DK1220667 T3 DK 1220667T3
Authority
DK
Denmark
Prior art keywords
infertility
beta antagonists
treat endometriosis
improve fertility
fertility
Prior art date
Application number
DK00964272T
Other languages
Danish (da)
English (en)
Inventor
William J Bologna
Howard L Levine
Dominique De Ziegler
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of DK1220667T3 publication Critical patent/DK1220667T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK00964272T 1999-10-05 2000-10-04 Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden DK1220667T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (fr) 1999-10-05 2000-10-04 Traitement de l'endometriose ou de l'infertilite ou amelioration de la fertilite

Publications (1)

Publication Number Publication Date
DK1220667T3 true DK1220667T3 (da) 2004-12-06

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00964272T DK1220667T3 (da) 1999-10-05 2000-10-04 Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden

Country Status (28)

Country Link
EP (1) EP1220667B1 (fr)
JP (2) JP2003510354A (fr)
KR (1) KR100738724B1 (fr)
CN (1) CN1218694C (fr)
AR (1) AR028487A1 (fr)
AT (1) ATE271860T1 (fr)
AU (1) AU780736B2 (fr)
BR (1) BR0014548A (fr)
CA (1) CA2385974C (fr)
CO (1) CO5251423A1 (fr)
DE (1) DE60012554T2 (fr)
DK (1) DK1220667T3 (fr)
ES (1) ES2223581T3 (fr)
GE (1) GEP20043313B (fr)
HK (1) HK1044120B (fr)
HU (1) HU225990B1 (fr)
IL (2) IL148784A0 (fr)
MA (1) MA25501A1 (fr)
MX (1) MXPA02003453A (fr)
MY (1) MY129518A (fr)
NO (1) NO329663B1 (fr)
NZ (1) NZ518429A (fr)
PE (1) PE20010742A1 (fr)
PT (1) PT1220667E (fr)
TR (1) TR200200899T2 (fr)
TW (1) TWI280877B (fr)
UA (1) UA74168C2 (fr)
WO (1) WO2001024788A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (fr) 2006-06-29 2008-01-02 Polichem S.A. Emploi d'une matrice hydrophile contenant un dérivé polyacrylique, un éther de cellulose et un désintégrant, pour la production d'un médicament pour le traitement des troubles génitales d'une femme
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
JP5894143B2 (ja) * 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド 抗黄体ホルモンの無毒送達のための組成物および方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
NZ702467A (en) 2012-05-31 2016-07-29 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
CN104755087A (zh) 2012-11-02 2015-07-01 利普生物药剂公司 治疗孕酮依赖性病况的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NZ518429A (en) 2004-02-27
WO2001024788A2 (fr) 2001-04-12
MY129518A (en) 2007-04-30
BR0014548A (pt) 2002-06-04
IL148784A (en) 2006-12-31
PT1220667E (pt) 2004-11-30
AR028487A1 (es) 2003-05-14
KR100738724B1 (ko) 2007-07-12
PE20010742A1 (es) 2001-07-19
CO5251423A1 (es) 2003-02-28
MA25501A1 (fr) 2002-07-01
DE60012554T2 (de) 2005-11-24
WO2001024788A3 (fr) 2001-12-06
EP1220667B1 (fr) 2004-07-28
JP2003510354A (ja) 2003-03-18
CA2385974C (fr) 2010-01-26
GEP20043313B (en) 2004-03-10
EP1220667A2 (fr) 2002-07-10
HK1044120A1 (en) 2002-10-11
HUP0203050A3 (en) 2006-02-28
AU780736B2 (en) 2005-04-14
MXPA02003453A (es) 2002-08-20
TR200200899T2 (tr) 2002-07-22
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
HUP0203050A2 (hu) 2003-02-28
IL148784A0 (en) 2002-09-12
NO329663B1 (no) 2010-11-29
CN1218694C (zh) 2005-09-14
KR20020062285A (ko) 2002-07-25
DE60012554D1 (de) 2004-09-02
CN1377264A (zh) 2002-10-30
CA2385974A1 (fr) 2001-04-12
HK1044120B (zh) 2004-12-17
ES2223581T3 (es) 2005-03-01
UA74168C2 (uk) 2005-11-15
HU225990B1 (en) 2008-02-28
ATE271860T1 (de) 2004-08-15
TWI280877B (en) 2007-05-11
NO20021591L (no) 2002-05-28
NO20021591D0 (no) 2002-04-04

Similar Documents

Publication Publication Date Title
NO20014607L (no) Sammensetninger til forbedring av fertilitet
PT1225874E (pt) Composicoes antivirais.
MXPA03001511A (es) Imidazol-5-il-2-amino-pirimidinas como agentes para la inhibicion de la proliferacion celular.
DE60023167T2 (de) Pyrazol-derivate als cannabinoidrezeptor-antagonisten
IS5706A (is) Adenosín A3 viðtakastillar
DK1161426T3 (da) Fremgangsmåde til fremstilling af furfural
DE60026222D1 (de) Betonzusatzmittel
CY2011002I1 (el) N-πυρραζολικοι αγωνιστες του α2α υποδοχεα
NO20022573L (no) N6-heterosykliske, 8-modifiserte adenosinderivater
DE69900552T2 (de) Kristallisierendes Glasurkomponentensystem
ATE317844T1 (de) Adenosine a2a receptor antagonisten
DK1200073T3 (da) Selektive iGluR5-receptorantagonister til behandling af migræne
DE60032310D1 (de) Netzsystem
DE60133931D1 (de) Kondensierte purinderivate als a1-adenosinrezeptorantagonisten
DK1220667T3 (da) Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden
NO20015259D0 (no) Substituerte bisykliske heterosykler, fremgangsmåte for deres fremstilling og deres anvendelse som antifedme oghyperkolesterolemiske midler
DE60043571D1 (de) Thermisches Schutzrelais
IS2196B (is) Blanda útskiptra bensimídasóla
DE29902351U1 (de) Verbundsystem
DE60036959D1 (de) Tensidzusammensetzungen, verbesserungsmittel enthaltend
DE50011761D1 (de) Fuse für halbleiteranordnung
DE60214408D1 (de) 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN
NO20014586L (no) Resorcinol sammensetninger
PT1015446E (pt) Derivados de (4-piperidinil)-1h-2-benzopirano uteis como agentes antipsicoticos
DK1607090T3 (da) Asimadolin til behandling af irritabel tyktarm (Irritable Bowel Syndrome)